Cargando…

Preparation and characterization of a fully human monoclonal antibody specific for human tumor necrosis factor alpha

Tumor necrosis factor alpha (TNFα) is an important inflammatory factor. It plays a cardinal role in inflammatory synovitis and articular matrix degradation, and is, therefore, a prime target for directed immunotherapy in autoimmune diseases. In this study, we screened and isolated the B cells secret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Xinmei, Liang, Hui, Pan, Jian, Zhang, Qian, Niu, Jiaqi, Xue, Cuili, Ni, Jian, Cui, Daxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809985/ https://www.ncbi.nlm.nih.gov/pubmed/34886761 http://dx.doi.org/10.1080/21655979.2021.1967710

Ejemplares similares

Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus
por: Tian, Puyuan, et al.
Publicado: (2019)

A Fully Human Inhibitory Monoclonal Antibody to the Wnt Receptor RYK
por: Halford, Michael M., et al.
Publicado: (2013)

ARV-825 Demonstrates Antitumor Activity in Gastric Cancer via MYC-Targets and G2M-Checkpoint Signaling Pathways
por: Liao, Xinmei, et al.
Publicado: (2021)

Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B
por: Matsumura, Takuhiro, et al.
Publicado: (2020)

Engineered Fully Human Single-Chain Monoclonal Antibodies to PIM2 Kinase
por: Kaewchim, Kanasap, et al.
Publicado: (2021)

Development of specific monoclonal antibodies for the detection of natural chicken tumor necrosis factor-alpha
por: Yang, Yi, et al.
Publicado: (2022)

Structural Insights into the Neutralization Properties of the Fully Human, Anti-interferon Monoclonal Antibody Sifalimumab
por: Oganesyan, Vaheh, et al.
Publicado: (2015)

Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells
por: Saha, Nayanendu, et al.
Publicado: (2023)

A Fully Human, Allosteric Monoclonal Antibody That Activates the Insulin Receptor and Improves Glycemic Control
por: Bhaskar, Vinay, et al.
Publicado: (2012)

Isolation, production and characterization of fully human monoclonal antibodies directed to Plasmodium falciparum MSP10
por: Maskus, Dominika J, et al.
Publicado: (2015)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Artificial intelligence in theranostics of gastric cancer, a review
por: Zha, Yiqian, et al.
Publicado: (2023)

Fully Human Monoclonal Antibody Inhibitors of the Neonatal Fc Receptor Reduce Circulating IgG in Non-Human Primates
por: Nixon, Andrew E., et al.
Publicado: (2015)

A fully human neutralizing monoclonal antibody targeting a highly conserved epitope of the human cytomegalovirus glycoprotein B
por: Okamoto, Miwa, et al.
Publicado: (2023)

Preclinical characterization of Sintilimab, a fully human anti-PD-1 therapeutic monoclonal antibody for cancer
por: Zhang, Shuang, et al.
Publicado: (2018)

[Corrigendum] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth
por: Xuan, Zi-Xue, et al.
Publicado: (2023)

BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer
por: Wang, Kan, et al.
Publicado: (2011)

Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors
Publicado: (1990)

Preparation of monoclonal antibody against human KIAA0100 protein and Northern blot analysis of human KIAA0100 gene
por: Cui, He, et al.
Publicado: (2017)

Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against Influenza A M2 protein
por: Beerli, Roger R, et al.
Publicado: (2009)

Preparation of Anti-Human Podoplanin Monoclonal Antibody and its application in Immunohistochemical Diagnosis
por: Xie, Chengjie, et al.
Publicado: (2018)

A novel fully human monoclonal antibody that neutralizes multiple human IFN-α subtypes effectively: a candidate therapy for SLE
por: Wang, Shuang, et al.
Publicado: (2015)

A first‐in‐human pharmacodynamic and pharmacokinetic study of a fully human anti‐glucagon receptor monoclonal antibody in normal healthy volunteers
por: Kostic, Ana, et al.
Publicado: (2017)

A fully human anti-c-Kit monoclonal antibody 2G4 inhibits proliferation and degranulation of human mast cells
por: Kim, Kwang-Hyeok, et al.
Publicado: (2022)

Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor
Publicado: (1990)

Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation
por: Kirkham, Bruce W, et al.
Publicado: (2014)

Systemic administration of an anti-tumor necrosis factor-alpha monoclonal antibody protects against endotoxin-induced uveitis in rats
por: Ge, Qingman, et al.
Publicado: (2016)

Anti-tumor necrosis factor-alpha monoclonal antibody suppresses colorectal cancer growth in an orthotopic transplant mouse model
por: Takasago, Takeshi, et al.
Publicado: (2023)

A phase Ia dose-escalation trial of Ametumumab (a fully human monoclonal antibody against epidermal growth factor receptor) in patients with advanced solid malignancies
por: Li, Da, et al.
Publicado: (2023)

A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological Choroidal Neovascularization in Mice
por: Seo, Songyi, et al.
Publicado: (2021)

Human natural killer cells for targeting delivery of gold nanostars and bimodal imaging directed photothermal/photodynamic therapy and immunotherapy
por: Liu, Bin, et al.
Publicado: (2019)

Identification of a Human Anti-Alpha-Toxin Monoclonal Antibody Against Staphylococcus aureus Infection
por: Liu, Fangjie, et al.
Publicado: (2021)

Effective preparation of a monoclonal antibody against human chromogranin A for immunohistochemical diagnosis
por: Zhang, Danping, et al.
Publicado: (2018)

Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.
por: Rowlinson-Busza, G., et al.
Publicado: (1995)

A fully caninised anti-NGF monoclonal antibody for pain relief in dogs
por: Gearing, David P, et al.
Publicado: (2013)

A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee
por: Cohen, Stanley B, et al.
Publicado: (2011)

In vitro and in vivo properties of a fully human IgG1 monoclonal antibody that combats multidrug resistant Pseudomonas aeruginosa
por: ADAWI, AZMI, et al.
Publicado: (2012)

Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice
por: Latres, Esther, et al.
Publicado: (2015)

Preclinical Characterization of GLS-010 (Zimberelimab), a Novel Fully Human Anti-PD-1 Therapeutic Monoclonal Antibody for Cancer
por: Lou, Beilei, et al.
Publicado: (2021)

The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment
por: Hauser, Stephen L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_77bc1nq7s4ij8brchj7558q9vn